当前位置: X-MOL 学术Aliment. Pharm. Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing
Alimentary Pharmacology & Therapeutics ( IF 7.6 ) Pub Date : 2024-04-23 , DOI: 10.1111/apt.18013
Tomohiro Fukuda 1 , Hajime Yamazaki 2 , Yusuke Miyatani 3 , Tsunaki Sawada 4 , Naoki Shibuya 5 , Yuka Fukuo 6 , Hiroki Kiyohara 7 , Hiromu Morikubo 8 , Keiichi Tominaga 9 , Kazuki Kakimoto 10 , Takayuki Imai 11 , Katsuki Yaguchi 12 , Shojiro Yamamoto 13 , Katsuyoshi Ando 14 , Nobuaki Nishimata 15 , Takeo Yoshihara 16 , Akira Andoh 11 , Toshifumi Hibi 3 , Katsuyoshi Matsuoka 17 ,
Affiliation  

Endoscopic healing (EH) is a therapeutic target in ulcerative colitis (UC). However, even patients who have achieved EH relapse frequently.

中文翻译:


内镜愈合的溃疡性结肠炎患者近期使用类固醇和复发风险



内镜愈合(EH)是溃疡性结肠炎(UC)的治疗目标。然而,即使达到 EH 的患者也经常复发。
更新日期:2024-04-23
down
wechat
bug